Nalaganje...

Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis

BACKGROUND: Tolvaptan has been approved in Japan for the treatment of hepatic edema. An important consideration in providing a clinical benefit to patients with liver cirrhosis is the improvement of ascites-related clinical symptoms. In the present post hoc analysis, we aimed to identify factors tha...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastroenterol
Main Authors: Sakaida, Isao, Terai, Shuji, Nakajima, Koji, Shibasaki, Yoshiyuki, Tachikawa, Sayaka, Tsubouchi, Hidetsugu
Format: Artigo
Jezik:Inglês
Izdano: Springer Japan 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5281662/
https://ncbi.nlm.nih.gov/pubmed/27379386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-016-1233-x
Oznake: Označite
Brez oznak, prvi označite!